COST OF CATARACT SURGERY AFTER IMPLANTATION OF THREE INTRAOCULAR LENSES WITH SQUARE EDGES
Author(s)
Andrew F Smith, PhD, Regional Health Economics Manager EUROPE1, Antoine Lafuma, MD, Director2, Viviane Jeanbat, MSc, Project manager2, Catherine Boureau, MD, Ophthalmologist3, Vincent Dubois, MSc, Surgical Marketing Division41Alcon Laboratories Ltd, Hemel Hempstead, Herts, United Kingdom; 2 Cemka-Eval, Bourg-la-Reine, France; 3 Ophthalmologist, Paris, France; 4 Laboratoire Alcon, Rueil Malmaison, France
OBJECTIVES: To compare the lifetime costs of complications due to posterior capsule opacification after cataract surgery in three types of IOLs, namely two hydrophobic lenses SA60AT, AR40E and one hydrophilic lens the XL-Stabi. METHODS: Costs were estimated from the results of a retrospective study of patients who underwent cataract surgery in 2001 and 2002 as well as from data in the literature. Data were analysed after a minimum of 3 years post-surgery using Kaplan-Meier survival curve analysis with the end event being time to Nd:Yag laser capsulotomy. Costs were calculated using two methods of extrapolation. The economic perspective was that of the French Sickness Fund. RESULTS: After 3 years of follow-up, the percentage of patients who had undergone Nd:Yag laser capsulotomy was 12.0% with the SA60AT, 25.2% with the AR40E and 51.0% with the XL-Stabi lenses (P<0.001). The total cost of capsulotomy and management of complications per patient lifetime was estimated to be 142.6 Euros for SA60AT, 273.4 Euros for AR40E ad 347.1 Euros for XL-Stabi using the first method of extrapolation, while using the second method of extrapolation, the costs were 242.8, 317.6 and 347.2 Euros, respectively. CONCLUSION: Lower costs for cataract surgery and management of related complications were observed with the SA60AT and AR40E IOL's with the lowest overall costs being observed in the SA60AT lens.
Conference/Value in Health Info
2007-10, ISPOR Europe 2007, Dublin, Ireland
Value in Health, Vol. 10, No. 6 (November/December 2007)
Code
PEY6
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Sensory System Disorders